ICE.WA Stock Analysis
IC
Uncovered
Medinice SA is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Medinice SA is engaged in providing cardiological & cardiosurgical devices and solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2018-09-25. The firm specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The firm cooperates with research centers in Poland and Europe. The company strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.